Skip to content
|RO
Biotechnology pharmaceutical production — sterile processing environment

Biotechnology Production Flow

BACK TO PHARMA

In biotechnology and modern pharmaceutical production, every stage of the technological flow must meet strict quality standards and microbiological contamination limits to achieve reproducibility. Klarwin integrates innovative solutions across the entire biotech production flow — from quality verification and raw material preparation, as well as cell cultivation, through to conditioning of the final product, packaging and quality control.

Our solutions cover systems for processing injectable, infusion, ophthalmic and radiopharmaceutical liquids — based on active pharmaceutical substances of synthetic, semi-synthetic or biological origin — including dosing, mixing, homogenization, aseptic sterilization or sterilization in the final container, transfer in sterile or controlled environments with isolators and RABS, and automated primary, secondary and tertiary packaging with serialization.

Single-use bioreactor system for pharmaceutical biotechnology production

Single-Use Bioreactor Systems

Single-use systems are the “standard” for flexibility, safety and efficiency in biopharmaceutical production. They eliminate cross-contamination risk and remove the time and resource cost associated with CIP/SIP stages for reusable equipment.

Pre-assembled sterile bioreactors and accessories support upstream and downstream processes — from mammalian cell cultures and recombinant protein production to vaccine manufacturing and advanced gene therapies.

Klarwin integrates:

Single-use bioreactors from laboratory to industrial scale
Integrated process control (pH, dissolved oxygen, temperature, agitation)
Pre-assembled sterile bags and single-use connection accessories
Technical assistance, validation and transition support from classical to single-use systems

Applications: vaccine production, monoclonal antibodies, therapeutic proteins, DNA/RNA-derived products, cell and gene therapies, pilot batches for clinical studies.

BACK TO PHARMA TECHNOLOGY

From cell to therapy — bioprocesses validated for biotech

Bioreactors, cell culture and downstream processing for vaccines, monoclonal antibodies, therapeutic proteins and cell & gene therapies. Klarwin integrates the technologies and validation expertise behind every clinical-grade batch.

CONTACT A CONSULTANT